Aaron L Slusher1, Brandon G Fico2, Katelyn M Dodge3, Ryan S Garten4, Peter J Ferrandi5, Alexandra A Rodriguez3, Gabriel Pena6, Chun-Jung Huang3. 1. School of Kinesiology, University of Michigan, Ann Arbor, MI, 48109, USA. alslush@umich.edu. 2. Department of Kinesiology and Health Education, The University of Texas at Austin, Austin, TX, 78712, USA. 3. Exercise Biochemistry Laboratory, Department of Exercise Science and Health Promotion, Florida Atlantic University, Boca Raton, FL, 33431, USA. 4. Department of Kinesiology and Health Sciences, Virginia Commonwealth University, Richmond, VA, 23284, USA. 5. College of Graduate Health Sciences, The University of Tennessee Health Science Center, Memphis, TN, 38163, USA. 6. Department of Kinesiology, University of Maryland-College Park, College Park, MD, 20742, USA.
Abstract
PURPOSE: Pentraxin 3 (PTX3) has been shown to be a predictor of endothelial dysfunction in patients with increased risk of cardiovascular disease (CVD) (e.g., obesity). Circulating PTX3 concentrations are dysregulated in obese individuals and are elevated following acute aerobic exercise. High-intensity interval exercise (HIIE) has been demonstrated to be as effective as continuous moderate-intensity exercise in improving endothelial function, as indicated by brachial artery flow-mediated dilation (BAFMD), in patients with CVD. Therefore, the purpose of this study was to examine the effect of acute HIIE on plasma PTX3 and BAFMD responses in obese individuals. METHODS: Eight obese and six normal-weight young males participated in acute HIIE (4 intervals of 4 min at 80-90% of VO2max; 3 min of active recovery at 50-60% VO2max). Plasma PTX3 and BAFMD were measured prior to, immediately following exercise, and one and 2 hours into recovery. RESULTS: Plasma PTX3 concentrations significantly increased following HIIE, yet the PTX3 response to HIIE was significantly blunted in obese compared to normal-weight participants. While the kinetic responses of BAFMD were also significantly different in obese compared to normal-weight participants, similar increases above the baseline were observed 2 hours into recovery in both groups. Finally, plasma PTX3 concentrations were not associated with BAFMD at baseline or in response to HIIE. CONCLUSION: The utilization of HIIE may serve as a time-efficient exercise prescription strategy to transiently improve endothelial function, independent of elevated plasma PTX3 concentrations, in obese individuals.
PURPOSE:Pentraxin 3 (PTX3) has been shown to be a predictor of endothelial dysfunction in patients with increased risk of cardiovascular disease (CVD) (e.g., obesity). Circulating PTX3 concentrations are dysregulated in obese individuals and are elevated following acute aerobic exercise. High-intensity interval exercise (HIIE) has been demonstrated to be as effective as continuous moderate-intensity exercise in improving endothelial function, as indicated by brachial artery flow-mediated dilation (BAFMD), in patients with CVD. Therefore, the purpose of this study was to examine the effect of acute HIIE on plasma PTX3 and BAFMD responses in obese individuals. METHODS: Eight obese and six normal-weight young males participated in acute HIIE (4 intervals of 4 min at 80-90% of VO2max; 3 min of active recovery at 50-60% VO2max). Plasma PTX3 and BAFMD were measured prior to, immediately following exercise, and one and 2 hours into recovery. RESULTS: Plasma PTX3 concentrations significantly increased following HIIE, yet the PTX3 response to HIIE was significantly blunted in obese compared to normal-weight participants. While the kinetic responses of BAFMD were also significantly different in obese compared to normal-weight participants, similar increases above the baseline were observed 2 hours into recovery in both groups. Finally, plasma PTX3 concentrations were not associated with BAFMD at baseline or in response to HIIE. CONCLUSION: The utilization of HIIE may serve as a time-efficient exercise prescription strategy to transiently improve endothelial function, independent of elevated plasma PTX3 concentrations, in obese individuals.
Authors: Peter J Ferrandi; Brandon G Fico; Michael Whitehurst; Michael C Zourdos; Fanchen Bao; Katelyn M Dodge; Alexandra L Rodriguez; Gabriel Pena; Chun-Jung Huang Journal: Life Sci Date: 2018-04-10 Impact factor: 5.037
Authors: Ceri L Atkinson; Nia C S Lewis; Howard H Carter; Dick H J Thijssen; Philip N Ainslie; Daniel J Green Journal: J Physiol Date: 2015-11-15 Impact factor: 5.182
Authors: Jonathan D Bartlett; Graeme L Close; Don P M MacLaren; Warren Gregson; Barry Drust; James P Morton Journal: J Sports Sci Date: 2011-03 Impact factor: 3.337
Authors: Yiannis S Chatzizisis; Ahmet Umit Coskun; Michael Jonas; Elazer R Edelman; Charles L Feldman; Peter H Stone Journal: J Am Coll Cardiol Date: 2007-06-08 Impact factor: 24.094
Authors: Rachel Hallmark; James T Patrie; Zhenqi Liu; Glenn A Gaesser; Eugene J Barrett; Arthur Weltman Journal: PLoS One Date: 2014-01-20 Impact factor: 3.240
Authors: Jenna B Gillen; Brian J Martin; Martin J MacInnis; Lauren E Skelly; Mark A Tarnopolsky; Martin J Gibala Journal: PLoS One Date: 2016-04-26 Impact factor: 3.240